Anal Basaloid Carcinoma
NCI Definition: An anal squamous cell carcinoma characterized by the presence of malignant cells with hyperchromatic nuclei and peripheral nuclear palisading. 
There is 1 clinical trial for anal basaloid carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains anal basaloid carcinoma as an inclusion criterion, 1 is phase 3 (1 open).
Nivolumab and observation are the most common interventions in anal basaloid carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.